Adel Alhabbal, Sameh Saber, Imad AbouKhamis
email@example.com , firstname.lastname@example.org
Adel Alhabbal1, Sameh Saber2*, Imad AbouKhamis1
1Department of Microbiology and Biochemistry, Faculty of Pharmacy, University of Damascus, Damascus, Syria.
2Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
Volume - 14,
Issue - 12,
Year - 2021
Celiac disease (CD) is a disorder caused by an aberrant autoimmune response to gluten ingestion in genetically susceptible individuals. Its prevalence nears 1%, and it is not considered typical in the Middle East because of the lack of reports in the Arabic countries. Therefore, this study aimed to define the prevalence of celiac disease in the Syrian community. Healthy young adults and volunteers ranging between 5–65-year-old were tested from December 2018 till May 2019. Samples from the participant's sera were tested for anti-tissue transglutaminase antibody (tTG) IgA/IgG by ELISA using the human recombinant transglutaminase antigen. One hundred participants with a mean ± SD of 22 ± 14 years-old were recruited in the study. Only one participant was suspected of having celiac disease. The mean ± SD of anti-tTG IgA/IgG values were 9.81 ± 9.61 for IgA and 6.64 ± 6.60 for IgG. The study shows no significant difference in IgA or IgG titers between males and females at P = 0.7, P = 0.8, respectively. The estimation of seroprevalence of CD antibodies in a healthy Syrian population is close to 1%. We suggest that the underdiagnosed CD might pose a high risk in Syria, contrary to previous thoughts.
Cite this article:
Adel Alhabbal, Sameh Saber, Imad AbouKhamis. The hidden danger in Syria: Silent Celiac Disease. Research Journal of Pharmacy and Technology. 2021; 14(12):6536-0. doi: 10.52711/0974-360X.2021.01130
Adel Alhabbal, Sameh Saber, Imad AbouKhamis. The hidden danger in Syria: Silent Celiac Disease. Research Journal of Pharmacy and Technology. 2021; 14(12):6536-0. doi: 10.52711/0974-360X.2021.01130 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-12-60
1 Cohen IS, Day AS, Shaoul R. Gluten in Celiac Disease-More or Less?. Rambam Maimonides Medical Journal. 2019 Jan 28;10 (1):e0007. doi: 10.5041/RMMJ.10360.
2 Sharma R. Visualising the Digestive Tract: Endoscopy. International Journal of Advances in Nursing Management. 2021;9(1):102-103. doi: 10.5958/2454-2652.2021.00026.3.
3 Rajalekshmi M, Shreedhara C S, Lobo R, Rao P. The review on genetics, epigenetics, risk factors and diagnosis of colon cancer. Research Journal of Pharmacy and Technology. 2018;11(11):5147-515. doi.org/10.5958/0974-360X.2018.00940.X.
4 Devi R. Gastroschisis. International Journal of Nursing Education and Research. 2021;9(1):108-112. PMID: 32491817.
5 Assa A, Frankel-Nir Y, Leibovici-Weissman Y, Tzur D, Afek A, Katz LH, Levi Z, Shameer R. Anthropometric measures and prevalence trends in adolescents with coeliac disease: a population based study. Archives of disease in childhood. 2017;102(2):139-144. doi: 10.1136/archdischild-2016-311376.
6 El-Gizawy SA, Nouh A, Saber S, Kira AY. Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats. Journal of Drug Delivery Science and Technology 2020;58:101732. doi.org/10.1016/j.jddst.2020.101732.
7 Saber S, Abd El-Kader EM, Sharaf H, El-Shamy R, El-Saeed Baraah, Mostafa A, Ezzat D, Shata A. Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats. Toxicology and Applied Pharmacology. 2020;400:115075. doi.org/10.1016/j.taap.2020.115075.
8 Saber S., Basuony M, Eldin AS. Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity. Archives of Biochemistry and Biophysics 2019;671:185-195. doi:10.1016/j.abb.2019.07.014.
9 Saber S, El-Kader EM. Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90/NLRP3 interaction and inducing autophagy in rats. Inflammopharmacology. 2021;29:237–251. doi:10.1007/s10787-020-00730-6.
10 Saber S, Khalil RM, Abdo WS, Nassif D, El-Ahwany E. Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk. Toxicology and Applied Pharmacology. 2019;364:120-132. doi.org/10.1016/j.taap.2018.12.020.
11 Saber S. et al. Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity. Naunyn-Schmiedeberg's Archives of Pharmacology. 2019;392: 1591-1604. doi:10.1007/s00210-019-01706-2.
12 Saber S. et al. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats. Life Sciences. 2021;270: 119123. doi.org/10.1016/j.lfs.2021.119123.
13 Abdel-Ghany R. et al. Blockade Of Pge2, Pgd2 Receptors Confers Protection Against Prepatent Schistosomiasis Mansoni In Mice. Journal of the Egyptian Society of Parasitology. 2015;45:511-520. doi:10.12816/0017911.
14 Mourad AAE, Khodir AE, Saber S, Mourad MAE. Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids. Pharmaceuticals. 2021;14(2):144. doi.org/10.3390/ph14020144.
15 Nasr M, Teiama M, Ismail A, Ebada A, Saber S. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis. Drug Delivery and Translational Research. 2020 Dec;10(6):1841-1852. doi:10.1007/s13346-020-00830-4.
16 Saber S. Angiotensin II: a key mediator in the development of liver fibrosis and cancer. Bulletin of the National Research Centre. 2018;42:18. doi:10.1186/s42269-018-0020-7.
17 Saber S, Ghanim AM, El-Ahwany E, El-Kader EMA. Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis. Cancer Chemotherapy and Pharmacology. 2020;85:331-343. doi:10.1007/s00280-020-04033-z.
18 Saber S, Goda R, El-Tanbouly GS, Ezzat D. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis. International Immunopharmacology. 2018;64:340-349. doi.org/10.1016/j.intimp.2018.09.021.
19 Saber S, Mahmoud A, Helal N, El-Ahwany E, Abdelghany, R. Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice. Open access Macedonian journal of medical sciences. 2018;6:955-960. doi:10.3889/oamjms.2018.167.
20 Saber S, Mahmoud A, Helal N, El-Ahwany E, Abdelghany, R. Losartan, an angiotensin-II type 1 receptor blocker, attenuates CCl4-induced liver fibrosis with a positive impact on survival in mice. world journal of pharmaceutical sciences. 2017;5:121-126.
21 Saber S, et al. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B. Toxicology letters. 2018;295:32-40. doi:10.1016/j.toxlet.2018.05.036.
22 Saber S, Mahmoud AA, Helal NS, El-Ahwany E, Abdelghany R. Renin-angiotensin system inhibition ameliorates CCl(4)-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B. Canadian journal of physiology and pharmacology. 2018;96:569-576. doi:10.1139/cjpp-2017-0728.
23 Younis NS, Ghanim AM, Saber S. Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma. Scientific Reports. 2019;9:19095. doi:10.1038/s41598-019-55666-x.
24 Saber S, et al. A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals. 2021;14(4):341. doi.org/10.3390/ph14040341
25 Lebwohl B, Sanders DS, Green PH. Lancet. 2018;6391(10115):70-81. doi: 10.1016/S0140-6736(17)31796-826.
26 Caio G. et al. Celiac disease: a comprehensive current review. BMC medicine. 2019;17:1-20. doi: 10.1186/s12916-019-1380-z
27 Satapathy T, Panda PK. Gastro Esophageal Reflux Disease (GERD) Pathogenesis, Diagnosis and Therapy. Research Journal of Pharmacy and Technology. 2013;6:130-136.
28 Kashyap S, Bajaj S, Hida. Prediction of student academics performance based on their previous performance and family support. Research Journal of Pharmacy and Technology. 2017;10:2075-2080. doi: 10.5958/0974-360X.2017.00362.6.
29 Meena P. A study to Evaluate the Effectiveness of Structured Teaching Programme on Knowledge Regarding Importance of Antenatal Checkup and Diagnostic Measures among Primi Mothers at Selected Community Area at Bangalore. International Journal of Advances in Nursing Management. 2016;4:384-387. doi: 10.5958/2454-2652.2016.00085.8
30 Al-Toma A, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterology Journal. 2019;7:583-613. doi: 10.1177/2050640619844125
31 Comba A, Eren NB, Demir E. Prevalence of celiac disease among school-age children in Çorum, Turkey. Turkish journal of gastroenterology. 2019;29(5):595. doi: 10.5152/tjg.2018.18020.
32 Mustalahti K, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Annals of Medicine. 2010;42:587-595. doi: 10.3109/07853890.2010.505931.
33 Dhole AR, et al. Drug used in inflammatory bowel disease (IBD)-Brief review. J. Pharmacology and P’dynamics. 2014;6(3):153-161
34 Manimaran A, Chandrasekaran V, Praba BJ. A review of fuzzy environmental study in medical diagnosis system. Research Journal of Pharmacy and Technology. 2016;9:177. doi: 10.5958/0974-360X.2016.00032.9.
35 Patel JB, et al. Functional Magnetic Resonance Imaging: A New Diversion in Medical Diagnosis. Research Journal of Pharmacy and Technology. 2011;4(8):1167-1176.
36 Sahu P. et al. Biomarkers: an emerging tool for diagnosis of a disease and drug development. Asian Journal of Research in Pharmaceutical Sciences. 2011;1:9-16.
37 King JA, et al. Incidence of celiac disease is increasing over time: a systematic review and meta-analysis. The American journal of gastroenterology. 2020;115(4):507-525. doi: 10.14309/ajg.0000000000000523.
38 Quan J, et al. A257 Association between Celiac Disease and Autism Spectrum Disorder: A Systematic Review. Journal of the Canadian Association of Gastroenterology. 2019;2(2):502-503. doi.org/10.1093/jcag/gwz006.256
39 Singh, P. et al. Global prevalence of celiac disease: systematic review and meta-analysis.clinical gastroenterology and hepatology. 2018;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.
40 Guandalini, S., Gupta, P. J. C. and Reviews, A. I. Celiac disease A diagnostic challenge with many facets. JAMA pediatrics. 2014;168(3):272-8. doi: 10.1001/jamapediatrics.2013.3858.